(Q56978257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

[Bosentan for treatment of active digital ulcers in patients with systemic sclerosis] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Luc Mouthon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Nadine Boullanger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Olivier Fain

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Patrick Jego

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Patrick Carpentier

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Pierre-Yves Hatron

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Elisabeth Diot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Elisabeth Pasquier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Eric Hachulla

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

587-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

The management of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Treating systemic sclerosis in 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Specific binding of endothelin on human vascular smooth muscle cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Endothelin and endothelin receptor antagonists in systemic rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Successful treatment of severe Raynaud's phenomenon with bosentan in four patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Resolution of severe digital ulceration during a course of Bosentan therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974645-0

7 January 2021

10.1016/S0755-4982(06)74645-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16614599%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference